These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11590490)

  • 1. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, January 28, 2000 by the Panel on Clinical Practices for Treatment of HIV Infection.
    ;
    HIV Clin Trials; 2000; 1(1):60-110. PubMed ID: 11590490
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. February 5, 2001.
    Panel on Clinical Practices for Treatment of HIV Infection
    HIV Clin Trials; 2001; 2(3):227-306. PubMed ID: 11590532
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for the use of antiretroviral agents in pediatric HIV infection, January 7, 2000.
    Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children.
    HIV Clin Trials; 2000; 1(3):58-99. PubMed ID: 11590506
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term HIV-1 suppression in the Brazilian public health system.
    de Sa-Filho DJ; de Arruda Souza T; Golegã AA; Diaz RS; Caseiro MM
    AIDS Patient Care STDS; 2009 May; 23(5):313-4. PubMed ID: 19327023
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy.
    Tamburrini E; Ravizza M; Floridia M; Tibaldi C; Alberico S; Anzidei G; Maccabruni A; Meloni A; Antoni AD; Mori F; Dalzero S; Conservan V; Pinnetti C; Ferrazzi E;
    Antivir Ther; 2008; 13(4):519-27. PubMed ID: 18672530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
    Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
    J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.
    Grant PM; Zolopa AR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):901-10. PubMed ID: 20721832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
    Sitnitskaya Y; Rochford G; Rigaud M; Essajee S; Pollack H; Krasinski K; Borkowsky W
    Clin Infect Dis; 2001 Jul; 33(1):e3-7. PubMed ID: 11389511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.
    van Zyl GU; van der Merwe L; Claassen M; Zeier M; Preiser W
    J Med Virol; 2011 Oct; 83(10):1764-9. PubMed ID: 21837793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation.
    MMWR Recomm Rep; 1998 Apr; 47(RR-5):43-82. PubMed ID: 9572121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens.
    Bunupuradah T; Ananworanich J; Chetchotisakd P; Kantipong P; Jirajariyavej S; Sirivichayakul S; Munsakul W; Prasithsirikul W; Sungkanuparph S; Bowonwattanuwong C; Klinbuayaem V; Petoumenos K; Hirschel B; Bhakeecheep S; Ruxrungtham K
    Antivir Ther; 2011; 16(7):1113-21. PubMed ID: 22024527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study.
    Dominguez S; Ghosn J; Peytavin G; Izzedine H; Wirden M; Ktorza N; Miller M; Aubron-Olivier C; Trylesinski A; Calvez V; Deray G; Katlama C
    J Med Virol; 2007 Feb; 79(2):105-10. PubMed ID: 17177308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intensification with abacavir in subjects at high risk for incomplete viral suppression.
    Bartlett JA; Tebas P; Bassett R; Huang W; Kuritzkes D; Reisler R; Loyack N; Robison K;
    Antivir Ther; 2003 Aug; 8(4):361-3. PubMed ID: 14518706
    [No Abstract]   [Full Text] [Related]  

  • 18. British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010.
    Gilleece Y; Chadwick DR; Breuer J; Hawkins D; Smit E; McCrae LX; Pillay D; Smith N; Anderson J;
    HIV Med; 2010 Nov; 11(10):611-9. PubMed ID: 20961377
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. U.S. Department of Health and Human Services (DHHS).
    BETA; 1997 Jun; ():11-22. PubMed ID: 11364535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of archived resistance after intrapartum nevirapine.
    S Afr Med J; 2004 May; 94(5):334-5. PubMed ID: 15211942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.